Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a novel series of orally available covalent ...
NIT Rourkela researchers have developed an AI-driven model for accurate blood sugar prediction, enhancing diabetes management ...
Insilico achieved preclinical milestone in its collaboration with Therasid Bioscience, a South Korean based biotechnology company focuses on developing innovative first-in-class drugs for treatment ...
We recently compiled a list of the Top 10 AI News Updates Analysts are Monitoring. In this article, we are going to take a ...
We recently published a list of 10 Oversold Biotech Stocks to Buy Now. In this article, we are going to take a look at where ...
Discover how AI is transforming the life sciences industry with insights from EY-Parthenon and Microsoft's strategic ...
President Trump issued a National Security Presidential Memorandum titled “America First Investment Policy,” outlining ...
A Saipan technology hub that is expected to pour in between $2.2 billion and $2.7 billion, create up to 10,000 new jobs, and ...
3d
GlobalData on MSNInovalon introduces AI-powered platform to expedite clinical trial recruitmentThe tool is designed to serve clinical trial sponsors and biotechnology, clinical trial recruitment and pharmaceutical ...
Chinese experts have expressed keen interest in introducing and testing new varieties of sesame and dragon fruit in Pakistan, ...
2d
The National Interest on MSNAmerica’s Vanishing Tech Edge: Reclaiming Leadership from ChinaIn February, The National Interest organized a symposium on the U.S.-China technology race amidst the emergence of DeepSeek and ongoing legal battles over TikTok. We asked a variety of experts the ...
Discover the world of therapeutic proteins, their applications, advantages, challenges, and future trends in healthcare and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results